Shield Therapeutics hosted an investor webinar on assuming full control of ACCRUFeR® in the US. CEO Anders Lundstrom, CCO Andy Hurley and Bryon Kallert presented an update, followed by a live Q&A. 🎥 Watch the recording: shieldtherapeutics.com/webin…

We're excited to announce that Michael Jensen will be joining Shield Therapeutics as Chief Financial Officer today. Please join us in giving Michael a warm welcome to the team!

📢 Today at 2:15 pm (BST): Shield Therapeutics present the latest update which announced that Shield will assume full commercial responsibility for ACCRUFeR® in the US. Still time to register 👇 shieldtherapeutics.com/webin…

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Interim results for the six months ended 30 Jun 26 Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Shield Therapeutics Q2/H1 2026 Trading Update webinar is now live. Hear from management on the latest commercial progress, financial highlights, and outlook for the year ahead, followed by a live Q&A with investors. 🎥 Watch here: shieldtherapeutics.com/webin…

📢 Today at 2:15pm (BST) - our Q2/H1 2026 Trading Update webinar. CEO Anders Lundstrom, CCO Andy Hurley and Bryon Kallert, Sr Director FP&A, will present our Q2/H1 2026 Trading Update and take questions live from shareholders. Still time to register 👇 shieldtherapeutics.com/webin…

We've just released the following announcement: Shield Therapeutics - Q2 and H1 2026 Trading Update Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - ACCRUFeR® Phase 3 pediatric trial published Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Wishing all of our team, partners, and investors across the US a very Happy Independence Day. Today is a great reminder of the values that inspire progress and the determination to keep building something better. Enjoy the long weekend, and have a safe and wonderful 4th of July

We've just released the following announcement: Shield Therapeutics - Block Listing 6 Monthly Return Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Results of 2026 Annual General Meeting Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

We've just released the following announcement: Shield Therapeutics - Total Voting Rights Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

Today, we mark International Nurses Day, celebrated each year on the birthday of Florence Nightingale to honour the vital contribution nurses make to healthcare worldwide. #InternationalNursesDay #NursingMatters #Healthcare #NHS #ThankYouNurses

Shield Therapeutics Q1 2026 Trading Update webinar is now live. Hear from management on ACCRUFeR® growth and what’s next. 🎥 Watch here: shieldtherapeutics.com/activ…

📢 Today at 2:15pm (BST) - our Q1 2026 Trading Update webinar. CEO Anders Lundstrom, CFO Santosh Shanbhag & CCO Andy Hurley will present, followed by Q&A. Still time to register 👇 shieldtherapeutics.com/s/fc9…

We've just released the following announcement: Shield Therapeutics - Grant of Share Options Check out the full announcement and join in with the conversation at: shieldtherapeutics.com/annou… #STX

CEO, Anders Lundstrom, CFO, Santosh Shanbhag, and CCO Andy Hurley will be hosting a live webinar relating to the Q1 2026 Trading Update at 2:15 pm (BST) on Tuesday 5 May 2026. To access the webinar please visit: shieldtherapeutics.com/webin…